Screening reveals Xenorhabdus budapestensis XH-4's potent antifungal effects in soybean, suggesting biofungicide potential.
Soybean root rot, primarily caused by Fusarium oxysporum, leads to severe root decay and substantial yield losses in Glycine max. This study screened ten entomopathogenic nematode-associated symbiotic bacteria for antagonistic activity against F. oxysporum. Among them, Xenorhabdus budapestensis XH-4 exhibited the strongest in vitro inhibition, suppressing mycelial growth by more than 73%. Antifungal activity was primarily attributed to extracellular metabolites, as both fermentation broth and cell-free culture supernatant were effective, whereas bacterial cell suspensions showed no significant inhibition. In greenhouse experiments, 40% (v/v) XH-4 reduced the disease index by 75–80%, comparable to the chemical fungicide metalaxyl–hymexazol. Genome mining revealed 20 biosynthetic gene clusters encoding diverse secondary metabolites, including fabclavine, fabclavine pyrrolizixenamide A, and putrebactin/avaroferrin, which likely underpin the strain antifungal efficacy. Additionally, XH-4 enhanced soybean antioxidant capacity and activated the phenylpropanoid pathway, indicating a dual mechanism involving direct antagonism and induced systemic resistance. These findings support the development of XH-4 as an environmentally friendly biofungicide for sustainable management of soybean root rot.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: